Safety and immunogenicity of an inactivated severe acute respiratory syndrome coronavirus 2 vaccine in a subgroup of healthy adults in Chile SM Bueno, K Abarca, PA González, NMS Gálvez, JA Soto, LF Duarte, ... Clinical Infectious Diseases 75 (1), e792-e804, 2022 | 120 | 2022 |
Recognition of variants of concern by antibodies and T cells induced by a SARS-CoV-2 inactivated vaccine F Melo-González, JA Soto, LA González, J Fernández, LF Duarte, ... Frontiers in immunology 12, 747830, 2021 | 77 | 2021 |
Immune profile and clinical outcome of breakthrough cases after vaccination with an inactivated SARS-CoV-2 vaccine LF Duarte, NMS Gálvez, C Iturriaga, F Melo-González, JA Soto, ... Frontiers in immunology 12, 742914, 2021 | 75 | 2021 |
Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial SM Bueno, K Abarca, PA González, NM Gálvez, JA Soto, LF Duarte, ... medrxiv, 2021.03. 31.21254494, 2021 | 73 | 2021 |
Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial K Abarca, E Rey-Jurado, N Munoz-Durango, Y Vázquez, JA Soto, ... EClinicalMedicine 27, 2020 | 41 | 2020 |
A booster dose of CoronaVac increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern BM Schultz, F Melo-González, LF Duarte, NMS Gálvez, GA Pacheco, ... MBio 13 (4), e01423-22, 2022 | 34 | 2022 |
Is there an association between indoor allergens and the severity of atopic dermatitis? BJ Cid, G Perez‐Mateluna, C Iturriaga, MJ Zambrano, MI Vives, ... International Journal of Dermatology 58 (4), 433-439, 2019 | 22 | 2019 |
Severe respiratory disease caused by human respiratory syncytial virus impairs language learning during early infancy M Peña, C Jara, JC Flores, R Hoyos-Bachiloglu, C Iturriaga, M Medina, ... Scientific Reports 10 (1), 22356, 2020 | 20 | 2020 |
Sleep quality in children with atopic dermatitis during flares and after treatment D Kahn, C Iturriaga, K Bertran, I Fernandez, G Perez-Mateluna, ... Sleep Science 13 (02), 172-175, 2020 | 18 | 2020 |
Diagnostic validity of fecal occult blood test in infants with food protein-induced allergic proctocolitis S Concha, C Cabalin, C Iturriaga, G Pérez-Mateluna, C Gomez, ... Rev Chil Pediatr 89 (5), 630-637, 2018 | 18 | 2018 |
Early origins of allergy and asthma (ARIES): study protocol for a prospective prenatal birth cohort in Chile CD Hernández, P Casanello, PR Harris, JA Castro-Rodríguez, C Iturriaga, ... BMC pediatrics 20, 1-9, 2020 | 17 | 2020 |
Prevalence of filaggrin loss‐of‐function variants in Chilean population with and without atopic dermatitis GV Cárdenas, C Iturriaga, CD Hernandez, M Tejos‐Bravo, ... International Journal of Dermatology 61 (3), 310-315, 2022 | 14 | 2022 |
Vitamin D modulates the allergic phenotype of dendritic cells in children with atopic dermatitis F Cristi, G Perez‐Mateluna, C Vera‐Kellet, S Silva‐Valenzuela, ... Experimental Dermatology 28 (3), 308-311, 2019 | 14 | 2019 |
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial NMS Gálvez, GA Pacheco, BM Schultz, F Melo-González, JA Soto, ... Elife 11, e81477, 2022 | 13 | 2022 |
Hertoghe's sign in atopic dermatitis A Borzutzky, M Tejos-Bravo, LF Venegas, C Iturriaga The Journal of Pediatrics 226, 299, 2020 | 12 | 2020 |
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize delta and omicron variants of concern BM Schultz, F Melo-González, LF Duarte, NMS Gálvez, GA Pacheco, ... medRxiv, 2021.11. 16.21266350, 2021 | 11 | 2021 |
Oral vitamin D modulates the epidermal expression of the vitamin D receptor and cathelicidin in children with atopic dermatitis C Cabalín, G Pérez-Mateluna, C Iturriaga, CA Camargo Jr, A Borzutzky Archives of Dermatological Research 315 (4), 761-770, 2023 | 10 | 2023 |
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults C Méndez, HF Peñaloza, BM Schultz, A Piña-Iturbe, M Ríos, ... EBioMedicine 91, 2023 | 9 | 2023 |
Safety and non-inferiority evaluation of two immunization schedules with an inactivated SARS-coV-2 vaccine in adults: A randomized clinical trial K Abarca, C Iturriaga, M Urzúa, N Le Corre, A Pineda, C Fernández, ... Vaccines 10 (7), 1082, 2022 | 9 | 2022 |
High prevalence of lupin allergy among patients with peanut allergy: Identification of γ-conglutin as major allergen R Aguilera-Insunza, C Iturriaga, A Mariñanco, L Venegas, G Aravena, ... Annals of Allergy, Asthma & Immunology 130 (2), 225-232, 2023 | 8 | 2023 |